QUARTERLY REPORT OF PURE BIOLOGICS S.A. FOR THE Q1 2022
| SELECTED FINANCIAL DATA | PLN thousand | PLN thousand | EUR thousand | EUR thousand | |
| 01.01.2022-31.03.2022 | 01.01.2021-31.12.2021 | 01.01.2022-31.03.2022 | 01.01.2021-31.12.2021 | ||
| I. Operating revenues | 3 112 | 3 709 | 670 | 811 | |
| II. Total operating costs | 8 572 | 6 770 | 1 845 | 1 481 | |
| III. Operating profit (loss) | (5 450) | (3 062) | (1 173) | (670) | |
| IV. Profit (loss) before tax | (6 360) | (3 132) | (1 369) | (685) | |
| V. Net profit (loss) | (6 360) | (3 132) | (1 369) | (685) | |
| VI. Net cash flows from operating activities | 2 758 | (10 989) | 593 | (2 403) | |
| VII. Net cash flows from investment activities | 24 363 | (85) | 5 243 | (19) | |
| VIII. Net cash flows from financial activities | (571) | 53 716 | (123) | 11 749 | |
| IX. Total net cash flows | 26 550 | 42 643 | 5 713 | 9 327 | |
| As at 31.03.2022 | As at 31.12.2021 | As at 31.03.2022 | As at 31.12.2021 | ||
| X. Total assets/liabilities | 49 315 | 47 190 | 10 600 | 10 260 | |
| XI. Tangible assets | 5 673 | 4 175 | 1 219 | 908 | |
| XII. Current assets | 43 642 | 43 015 | 9 380 | 9 352 | |
| XIII. Equity capital | 34 215 | 39 486 | 7 354 | 8 585 | |
| XIV. Liabilities and provisions for liabilities | 15 100 | 7 704 | 3 246 | 1 675 | |
| XV. Long-term liabilities | 2 509 | 2 155 | 539 | 468 | |
| XVI. Short-term liabilities | 12 591 | 5 549 | 2 706 | 1 206 | |
| XVII. Weighted average number of ordinary shares | 2 254 000 | 2 221 123 | 2 254 000 | 2 221 123 | |
| XVIII. Profit (loss) per ordinary share (in PLN/EUR) | (2,82) | (1,41) | (0,61) | (0,31) | |
| XIX. Number of shares at the end of the period | 2 254 000 | 2 254 000 | 2 254 000 | 2 254 000 | |
| XX. Book value per share (in PLN/EUR) | 15,18 | 17,78 | 3,26 | 3,87 | |
|
|
|||||
| The selected financial figures presented in the report have been converted into euro as follows: | |||||
| 1] Items relating to the statement of profit or loss and other total income, the cash flow statement and the statement of changes in equity were converted at an exchange rate representing the arithmetic average of the exchange rates published by the National Bank of Poland: | |||||
| – period between 01.01.2022 – 31.03.2022: PLN 4,6472 | |||||
| – period between 01.01.2021 – 31.03.2021: PLN 4,5721 | |||||
| 2] The balance sheet items were converted according to the average exchange rate announced by the National Bank of Poland, in force on the balance sheet date; this exchange rate amounted to: | |||||
| – As at 31 March 2022: PLN 4,6525 | |||||
| – As at 31 December 2021: PLN 4,5994 | |||||
| – As at 31 March 2021: PLN 4,5721 | |||||